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anti-IgD MAb (Smiley et al., 1997), or the nonprotective
T cell response to leishmaniasis in susceptible BALB/c
mice (Launois et al., 1995). In addition, NKT cellsmediate
IL-12-induced tumor rejection in vivo (Hashimoto et al.,
1995; Takeda et al., 1996; Cui et al., 1997), produce
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IFN-g (Kawamura et al., 1998), and are cytotoxic againstSwitzerland
common murine tumor targets in vitro when isolated
from IL-12-treated mice (Hashimoto et al., 1995), sug-
gesting that NKT cells are implicated in certain Th1 re-Summary
sponses. Other experiments indicate that NKT cells reg-
ulate autoimmunity. In aging lpr/lpr mice or (NZB 3Natural killer T (NKT) cells express a T cell receptor
NZW)F1 mice, the onset of disease correlates with a(TCR) and markers common to NK cells, including
reduction in NKT cells (Mieza et al., 1996). Moreover,NK1.1. In vivo, NKT cells are triggered by anti-CD3e
insulin-dependent diabetes mellitus (IDDM) in NOD miceMAb to rapidly produce large amounts of IL-4 and by
is prevented by the transfer of IL-4- and/or IL-10-pro-IL-12 to reject tumors. We show here that anti-CD3e
ducing NKT cells (Hammond et al., 1998b). In humans,MAb treatment rapidly depletes the liver (and partially
IDDM (Wilson et al., 1998) and systemic sclerosis (Su-the spleen) of NKT cells and that homeostasis is
mida et al., 1995) correlate with a decrease in Va24-JaQachieved 1 to 2 days later via NKT cell proliferation
T cells, the human homologs of murine Va14-Ja281 NKTthat occurs mainly in bone marrow. Similar results
cells. In the case of IDDM, disease is associated with awere obtained in mice treated with IL-12. Collectively,
loss of IL-4 but not of IFN-g production by Va24-JaQ Tour data demonstrate that peripheral NKT cells are
cells. Thus, the capacity of NKT cells to act as Th1- orhighly sensitive to activation-induced cell death and
Th2-like cellsmay play a pivotal role in particular diseasethat bone marrow plays a major role in restoring NKT
models as well as clinical diseases.cell homeostasis.
In normal adult mice, NKT cells are found in liver,
spleen, bone marrow, and thymus at a level of 0.5 to
Introduction 1.5 million cells per organ (Yankelevich et al., 1989; Bal-
las and Rasmussen, 1990; Sykes, 1990; Bendelac et al.,
Natural killer T (NKT) cells are defined as T cells bearing
1994, 1997; Ohteki and MacDonald, 1994). NKT cells are
the common NK cell marker NK1.1 (a member of the rare in lymph nodes and virtually absent from gut IEL.
NKR-P1 gene family) (MacDonald, 1995; Bendelac et al., The developmental relationship between NKT cells in
1997). Like NK cells they express IL-2Rb (CD122) and these different tissues is controversial. NKT cells can
like activated T cells they express the very early activa- be generated in fetal thymic organ cultures (Bendelac
tion antigen CD69 and low levels of L-selectin (CD62L). et al., 1994), and neonatal thymus grafts implanted in
The TCRab repertoire of NKT cells usually consists of an congenitally athymic (nude) mice give rise to low num-
invariant Va14-Ja281 chain (Lantz and Bendelac, 1994) bers of NKT cells in the recipient organs (Levitsky et al.,
paired preferentially with a polyclonal Vb8.2 chain, or to 1991), suggesting that NKT cells develop in the thymus.
a lesser extent, Vb7 and Vb2 chains (Arase et al., 1992; On the other hand, NKT cells are also detected in bone
Ohteki and MacDonald, 1994, 1996). The MHC class marrow (Sykes, 1990), spleen (Kikly and Dennert, 1992),
I±like molecule CD1d positively selects this highly skewed and liver (Hashimoto et al., 1995) of nude mice, and
TCRab repertoire (Bendelac, 1995; Chen et al., 1997; reconstitution of adult thymectomized irradiated mice
Mendiratta et al., 1997; Smiley et al., 1997). The groove with syngeneic bone marrow cells gives rise toNKT cells
found within the CD1d molecule is more profound and in the recipient organs (Sato et al., 1995), suggesting that
hydrophobic than its counterpart in classical MHC mole- NKT cells can develop extrathymically from the bone
cules (Zeng et al., 1997), suggesting that NKT cells rec- marrow.
ognize CD1d-bound lipid ligands, such as ceramids In this report, we have studied the effect of admin-
(Kawano et al., 1997) or glycosylphosphatidylinositols istrating anti-CD3e MAb or IL-12 on the turnover of NKT
(Joyce et al., 1998). cells in vivo. Both treatments have been shown to acti-
The physiological function of NKT cells remains un- vate NKT cells and have been extensively used as mod-
known. They rapidly produce large amounts of IL-4 in els to study NKT cell function (Yoshimoto and Paul,
vivo upon administration of anti-CD3e MAb (Yoshimoto 1994; Hashimoto et al., 1995; Bendelac et al., 1996;
and Paul, 1994) and also IFN-g, IL-3, IL-4, IL-5, and IL- Takeda et al., 1996; Chen et al., 1997; Cui et al., 1997;
10 when activated in vitro (Arase et al., 1993, 1996; Chen Emoto et al., 1997a, 1997b; Mendiratta et al., 1997; Smi-
and Paul, 1997). Despite their ability to produce large ley et al., 1997). A rapid depletion of NKT cells was
amounts of IL-4, they have not been found to be neces- observed in liver and, toa lesser extent, in spleenof mice
sary for the induction of typical Th2 responses, such as treated with either anti-CD3e MAb or IL-12. Moreover,
the secretion of IgG1 and IgE upon administration of repopulation of NKT cells in these tissues also occurred
rapidly (within 48 hr), suggesting that homeostasis of
peripheral NKT cells is tightly controlled. Continuous*To whom correspondence should be addressed (e-mail: HughRob
son.MacDonald@isrec.unil.ch). BrdU-labeling and cell cycle analysis of NKT cells in
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Figure 1. Depletion of NKT Cells upon Administration of Anti-CD3e MAb
Mice were injected i.v. with PBS or 0.2 mg of hamster anti-CD3e MAb. One day later, the indicated organs were removed and the cells stained
with (A) anti-CD3 MAb-FITC and anti-NK1.1 MAb-PE or (B) anti-CD4 MAb-FITC and anti-NK1.1 MAb-PE. The percentage of cells in each
subset is indicated. Similar results were obtained when PBS was substituted with control hamster IgG. One representative experiment out of
10 is shown.
liver, spleen, bone marrow, and thymus of mice treated anti-CD3e MAb induced depletion of 90% of liver NKT
cells within 24 hr, whereas NK cells and conventional Twith anti-CD3e MAb or IL-12 further identified bone mar-
row as the major site of NKT cell proliferation. Collec- cells in liver were apparently not affected (Figure 1A).
A pronounced depletion (60%) of NKT cells was alsotively, our data indicate that peripheral NKT cells are
rapidly deleted upon activation and replaced by NKT observed in spleen, while depletion was marginal in
bone marrow and not significant in thymus. The use ofcells that have been generated by de novo proliferation
in bone marrow. other combinations of markers to identify NKT cells,
such as NK1.1 and CD4 (70% of liver NKT cells are
CD41) (Figure 1B), gave similar results.Results
Kinetic studies revealed significant depletion of liver
NKT cells as early as 90 min after injection of anti-CD3eSteady State Turnover of NKT Cells
in Different Tissues MAb, and maximal depletion was achieved within 10 to
20 hr (Figure 3). Furthermore, repopulation of liver NKTWe first determined the steady state turnover of NKT
(NK1.11 CD31) cells in liver, spleen, bone marrow, and cells began 1 day after injection of anti-CD3e MAb and
was complete within 2 days (Figure 3). This rapid modu-thymus of adult C57Bl/6 mice. Figure 1A shows the
percentage of NKT cells among total mononuclear cells lation of liver NKT cells by anti-CD3e MAb suggested
three (non±mutually exclusive) hypotheses. First, allin each of these tissues (upper panels). The steady-state
turnover of NKT cells was determined by injecting mice markers tested (CD3, CD4, and NK1.1) were down-regu-
lated and subsequently up-regulated upon stimulationtwice i.p. within 24 hr with 2 mg of the thymidine analog
BrdU. Mice were killed and NKT cells in the different of NKT cells by anti-CD3e MAb. Second, NKT cells were
stimulated to emigrate from the liver and later immigratetissues were electronically sorted and stained with an
anti-BrdU MAb (Figure 2). NKT cells in bone marrow had back to the liver. Third, NKT cells were stimulated to
die, eliminated, and replaced by new NKT cells as aa significantly higher turnover than NKT cells in other
tissues. consequence of proliferation of remaining cells in the
liver or elsewhere.
Anti-CD3e-Mediated Depletion and
Repopulation of NKT Cells Mechanism of Depletion of Liver NKT Cells
As mentioned above, the rapid disappearance of liverMice were injected i.v. with different doses of anti-CD3e
MAb ranging from 0.02 to 2 mg. As little as 0.2 mg of NKT cells in anti-CD3e-treated mice could reflect either
Figure 2. Turnover of NKT Cells in Untreated
Mice
Mice were injected twice i.p. at 12 hr intervals
with 2 mg of BrdU. After an additional 12 hr,
NKT cells were purified by electronic sorting
from liver, spleen, bone marrow, and thymus
and stained with anti-BrdU MAb. Numbers
are the mean BrdU1 cells (6 SD) in three
(spleen), five (thymus), oreight (liver and bone
marrow) independent experiments.
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to phosphatidylserine, which is normally confined to the
inner leaflet of the plasma membrane (Martin et al.,
1995). Phosphatidylserine externalization, among other
plasma membrane changes, is an early event in cells
undergoing apoptosis that may allow phagocytes to rec-
ognize and engulf damaged cells before they rupture.
Figure 4B shows that liver NKT cells isolated from mice
2 hr after injection of anti-CD3e MAb had a significant
increase in Annexin V binding activity as compared to
NKT cells isolated from PBS-treated mice. This increase
in Annexin V binding was transient and only associated
with the depletion of liver NKT cells, since it was not
observed 24 hr after anti-CD3e injection when repopula-
Figure 3. Kinetics of Depletion and Repopulation of Liver NKT Cells tion of liver NKT cells was occurring. Moreover, in-
Mice were injected i.v. with 0.2 mg of anti-CD3e MAb. After different creased Annexin V binding on NKT cells from anti-CD3e-
periods of time, livers were removed and the cells stained with treated mice was restricted to tissues in which depletion
anti-CD3 MAb-FITC and anti-NK1.1 MAb-PE. The results are the of NKT cells occurred, since no such increase could
compilation of 12 independent experiments and the curves are (left be detected in the thymus (Figure 4B). Taken together,
panel) linear or (right panel) nonlinear regressions of the data points.
these results demonstrate that liver NKT cells undergo
apoptosis (and most likely removal by phagocytes)
within hours after anti-CD3e MAb injection. It is not clearsurface marker down-regulation, emigration, or apopto-
however whether NKT cells die in situ in the liver orsis. To address the issue of a possible change of NKT
emigrate and die elsewhere.cell surface phenotype, we took advantage of the fact
that the TCR Vb repertoire of NKT cells is heavily biased
Repopulation of Liver NKT Cells
towards Vb8.2 (Arase et al., 1992; Ohteki and MacDon- Requires Proliferation
ald, 1994, 1996). As shown in Figure 4A, 48% of liver
If liver NKT cells are eliminated by apoptosis in anti-
NKT cells in normal C57Bl/6 mice express Vb8.2, as CD3e-treated mice, one might anticipate that repopula-
compared to only 11% of conventional (CD31 NK1.12) tion would require proliferation of cells that have sur-
T cells. Importantly, the percentage of Vb8.21 NKT and vived depletion. To test this prediction, mice were fed
T cells was unchanged either 2 or 24 hr after injection continuously with BrdU in their drinking water starting
of anti-CD3e MAb, despite the fact that up to 90% of 1 day before injection of anti-CD3e MAb. At different
NKT cells had been depleted during this time period. time points after anti-CD3e MAb injection, liver NKT cells
These data formally exclude down-regulation of NK1.1 were purified by electronic sorting and stained with anti-
as an explanation for the disappearance of liver NKT BrdU MAb. Figure 5A shows a representative experi-
cells in anti-CD3e-treated mice. Moreover, no surface ment where most (85%) repopulating liver NKT cells
CD32 cells expressing intracellular Vb8.2 could be de- were BrdU1 after 32 hr in anti-CD3e-treated mice, while
tected in the liver of anti-CD3e-treated mice (data not the proportion of BrdU1 NKT cells in PBS-injected mice
shown), thus excluding CD3 downmodulation by NKT was marginal (5%). Repopulation of liver NKT cells was
cells. Collectively, the Vb8.2 staining data formally dem- therefore the consequence of proliferation. It was not
onstrate that liver NKT cells do not down-regulate NK1.1 clear however whether the repopulating liver NKT cells
and/or CD3 following anti-CD3e treatment. originated from liver NKT cells that had escaped deple-
We then investigated whether liver NKT cells undergo tion or from NKT cells (or their precursors) present in
other tissues.apoptosis in anti-CD3e-treated mice. Annexin V binds
Figure 4. Apoptosis of Liver NKT Cells in
Anti-CD3-Treated Mice
Mice were injected i.v. with PBS or 0.2 mg of
anti-CD3e MAb, and organs were removed 2
or 24 hr after injection as indicated. (A) Liver
cells were stained with anti-CD3 MAb-FITC,
anti-NK1.1 MAb-biotin (plus streptavidin-Tri-
color), and anti-Vb8.2 MAb-PE. The histo-
grams correspond to Vb8.2 staining gated on
NKT (CD31 NK1.11) or T (CD31 NK1.12) cells.
The percentage of Vb8.21 cells in each subset
is indicated. (B) Liver or thymus cells were
stained with anti-CD3 MAb-biotin (plus strep-
tavidin-Tricolor), anti-NK1.1 MAb-PE, Annexin
V-FITC, and propidium iodide to exclude
dead cells. Closed histograms represent
Annexin V binding to NKT cells from anti-
CD3-treated mice, whereas empty histo-
grams represent Annexin V binding to NKT
cells from mice injected with PBS. One repre-
sentative experiment out of four is shown.
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Figure 5. Bone Marrow Is a Major Site of NKT
Cell Proliferation
Mice were fed continuously with BrdU in their
drinking water starting 1 day before i.v. injec-
tion of anti-CD3e MAb. At various time points,
NKT cells were purified by electronic sorting
from liver, spleen, bone marrow, and thymus.
The sorted cells were stained simultaneously
with anti-BrdU MAb and PI. (A) NKT cells from
PBS- or anti-CD3e-treated mice were purified
and stained32 hr after treatment. (B) Absolute
numbers of total NKT cells, BrdU1 NKT cells,
and NKT cells in S or G2/M phase of the cell
cycle per time point and per tissue. Absolute
numbers of NKT cells are calculated on the
basis of total mononuclear cells in liver (4 3
106) or total nucleated cells in spleen (100 3
106), bone marrow (300 3 106) (Opstelten and
Osmond, 1983), and thymus (100 3 106). For
time point 0, mice were fed with BrdU for 50
hr and injected with PBS at day 1 of BrdU
feed.
Bone Marrow Is the Major Site of NKT Cell were found to be in S or G2/M phase at any time point.
In bone marrow, the vast majority (95%) of NKT cellsProliferation in Anti-CD3e-Treated Mice
To identify the site of NKT cell proliferation in anti-CD3e- became BrdU1 during the repopulation phase, even
though depletion had been marginal. This was explainedtreated mice, we performed the following experiment.
Mice were fed continuously with BrdU in their drinking by the finding that 35% to 50% of total bone marrow
NKT cells and a majority of BrdU1 cells were in S orwater starting 1 day before injection of anti-CD3e MAb.
At different time points after anti-CD3e MAb injection, G2/M phase between 20 and 30 hr after injection of anti-
CD3e MAb. Moreover, they displayed increased forwardNKT cells were purified by electronic sorting from the
organs containing significant numbers of NKT cells and side light scatter characteristic of blast cells. The
proportion of bone marrow NKT cells in S or G2/M phase(namely liver, spleen, bone marrow, and thymus). The
sorted cells were stained simultaneously with anti-BrdU decreased thereafter, concomitant with a slower rate of
increase in BrdU1 cells. Finally, no significant numbersMAb (to determine the number of cells that had prolifer-
ated or were proliferating) and with propidium iodide of BrdU1 NKT cells or NKT cells in S or G2/M phase
were found in thymus at any time point after anti-CD3e(PI) (to determine the number of cells that were in S or
G2/M phase of the cell cycle, i.e., that were proliferating MAb injection. These data clearly show that the number
of liver and spleen NKT cells in S or G2/M phase couldat the time the mice were killed). A representative exam-
ple of BrdU/PI staining of NKT cells in each tissue (mea- not account for the increase in BrdU1 cells in these
tissues, whereas bone marrow (which contained up tosured 32 hr after anti-CD3e MAb injection) is shown in
Figure 5A and the complete kinetics of depletion and 15-fold more cycling NKT cells than liver) appears to be
the major site of NKT cell proliferation. (Note that therepopulation in Figure 5B. The absolute number of NKT
cells in liver and spleen was minimal 10 and 20 hr after number of bone marrow NKT cells found in S or G2/M
phase during the repopulation phase is an underestima-injection of anti-CD3e MAb and represented 10% and
30% of the initial number of NKT cells, respectively. A tion of the total number of NKT cells produced, since
each cycling NKT cell presumably gives rise to twomarginal decrease was also observed in bone marrow
but no effect was apparent in thymus, as shown pre- daughter cells.)
A final possibility to account for the repopulation ofviously in Figure 1. During the repopulation phase start-
ing 20 to 24 hr after anti-CD3e MAb injection, almost all liver NKT cells was that proliferation occurred in situ in
precursors of NKT cells (i.e., cellsputatively not express-(95%) liver NKT cells were BrdU1 (as mentioned before),
whereas 70% of spleen NKT cells were BrdU1. In con- ing NK1.1 and/or CD3) that subsequently differentiated
into NKT cells. Although this hypothesis seems unlikelytrast, very few (less than 15%) liver and spleen NKT cells
Homeostasis of NKT Cells
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Figure 6. Kinetics of Depletion and Repopu-
lation of NKT Cells in Adult Thymectomized
Mice
Thymectomized (Thx) or sham thymecto-
mized (Shx) mice were injected i.v. with 0.2
mg of anti-CD3e MAb and fed continuously
with BrdU in their drinking water starting 1
day before i.v. injection of anti-CD3e MAb. At
various time points, NKT cells were purified
by electronic sorting from liver and bone mar-
row. The sorted cells were stained simultane-
ously with anti-BrdU MAb and PI. Data are
presented as absolute numbers of total NKT
cells, BrdU1 NKT cells, and NKT cells in S or
G2/M phase of the cell cycle per time point
and per tissue (see legend to Figure 5). For
time point 0, mice were fed with BrdU for 3
consecutive days and injected with PBS at
day 1 of BrdU feed.
since regeneration was very rapid in this system, we has been shown to induce both activation (Hashimoto
et al., 1995; Takeda et al., 1996; Cui et al., 1997) andnevertheless purified all four populations of cells defined
by NK1.1 and CD3 from livers of mice that had been depletion (Emoto et al., 1997a, 1997b) of NKT cells in
vivo. As shown in Figure 7A, liver NKT cells were de-injected 24 hr before with anti-CD3e MAb. Staining of
these populations with PI revealed that the number of pleted in mice treated with IL-12, but conventional T
cells and NKcells were apparently not affected. To studyconventional NK cells and T cells as well as of non-NK
non-T cells in S or G2/M phase was indeed not signifi- NKT cell repopulation and proliferation in this system,
mice were fed continuously with BrdU in their drinkingcant (data not shown). Thus, repopulating NKT cells in
liver did not arise from NK1.12 and/or CD32 cells in situ. water starting 1 day before i.v. injection of 0.5 mg of IL-
12. At different time points after IL-12 injection, NKT
cells were purified by electronic sorting from liver andThymus-Independent NKT Cell Repopulation
Several lines of evidence suggest that the thymus is bone marrow and stained simultaneously with anti-BrdU
MAb and PI. Figure 7B shows that the absolute numberinvolved in the normal development of NKT cells (Levit-
sky et al., 1991; Bendelac et al., 1994). Therefore, we of liver NKT cells was minimal between 1 and 2 days
after IL-12 injection and represented 10% of the initialasked whether the thymus was involved in the repopula-
tion of peripheral NKT cells upon injection of anti-CD3e number of NKT cells, whereas the decrease in bone
marrow was much less pronounced. During the repopu-MAb, either directly by supplying the liver and spleen
with NKT cells (which was excluded in the experiment lation phase starting 2 days after IL-12 injection, almost
all liver NKT cells were BrdU1 but very few were in S orreported in Figure 5) or indirectly by promoting the sup-
ply of NKT cells from other organs. To study NKT cell G2/M phase at any time point. In bone marrow, most
NKT cells became BrdU1 during the repopulation phase,repopulation and proliferation in the absence of thymus,
thymectomized and sham thymectomized mice were and z40% of the total NKT cells and a majority of BrdU1
cells were in S or G2/M phase between 1 and 2 daysfed continuously with BrdU in their drinking water start-
ing 1 day before i.v. injection of anti-CD3e MAb. At differ- after IL-12administration. The turnover of liver NKT cells
in IL-12-treated mice was thus very similar to that ob-ent time points after injection, NKT cells were purified
by electronic sorting from liver and bone marrow and served in anti-CD3e-treated mice, except that repopula-
tion was delayed by 1 day.stained simultaneously with anti-BrdU MAb and PI. Re-
population of liver NKT cells was found to be as efficient
in thymectomized mice as in control mice, and most
Discussionrepopulating NKT cellswere BrdU1 (Figure6). Moreover,
most NKT cells in S or G2/M phase were found in bone
It is well established that administration of anti-CD3emarrow. Since depletion and repopulation of NKT cells
MAb in vivo triggers NKT cells to produce large amountsin thymectomized and control mice were very similar,
of IL-4 in a very short period of time (Yoshimoto andany role of the thymus in the rapid repopulation of pe-
Paul, 1994; Bendelac et al., 1996; Chen et al., 1997;ripheral NKTcells upon injection of anti-CD3e MAb could
Mendiratta et al., 1997; Smiley et al., 1997). In spleenbe formally excluded.
NKT cells, IL-4 production starts as early as 30 min after
anti-CD3e treatment, peaks at 1.5 hr, and decreasesIL-12-Mediated Depletion and Repopulation
thereafter tobarely detectable levels 4 hrafter treatmentof NKT Cells
(Yoshimoto and Paul, 1994). We report here that anti-In an attempt to generalize our findings obtained with
CD3e treatment also depletes peripheral organs (liveranti-CD3e MAb, we analyzed the effect of IL-12 treat-
ment on the turnover of NKT cells, since this cytokine and to a lesser extent spleen) of NKT cells. Surprisingly,
Immunity
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Figure 7. IL-12-Mediated Depletion and Re-
population of NKT Cells
Mice were fed continuously with BrdU in their
drinking water starting 1 day before i.v. injec-
tion of IL-12. At various time points, NKT cells
were purified by electronic sorting from liver
and bone marrow. The sorted cells were
stained simultaneously with anti-BrdU MAb
and PI.
(A) Total cells from PBS- or IL-12-treated
mice were isolated 2 days after treatment and
analyzed for CD3 and NK1.1 expression be-
fore electronic sorting.
(B) Absolute numbers of total NKT cells,
BrdU1 NKT cells, and NKT cells in S or G2/M
phase of the cell cycle per time point and per
tissue (see legend to Figure 5). For time point
0, mice were fed with BrdU for 3 to 5 consecu-
tive days and injected with PBS at day 1. Note
the high proportion (40%) of BrdU1 NKT cells
present in untreated (PBS) mice (time 0). This
proportion was high in occasional batches of
mice but did not exceed 5% in most cases
(see Figures 2, 5, and 6). One representative
experiment out of three is shown.
this depletion was very rapid, beginning as early as 90 conventional T cells in peripheral tissues (Hirsch et al.,
1988). Although this exquisite sensitivity to AICD couldmin after MAb treatment, and was the consequence of
NKT cell apoptosis. Thus, anti-CD3e-mediated activa- be an intrinsic lineage-specific property of NKT cells,
it is also possible that it is a reflection of their activationtion of NKT cells is rapidly followed by deletion, a pro-
cess termed activation-induced cell death (AICD) (Rus- status. In this regard, AICD of conventional T cells
normally occurs only after several rounds of antigen-sell, 1995).
Both the doses of anti-CD3e MAb required to induce induced cell division (Renno et al., 1995). However, TCR
cross-linking of previously activated conventional TIL-4 production by NKT cells in vivo and the level of IL-4
production induced in different tissues (Yoshimoto and cells leads rapidly to apoptosis (Lenardo, 1991; Boehme
and Lenardo, 1993). Since NKT cells constitutively ex-Paul, 1994) are concordant with the data obtained here
on deletion of NKT cells. Thus, low doses of anti-CD3e press markers normally associated with activated T cells
(CD44high CD62Llow CD69high) (Bendelac et al., 1997), it isMAb (less then 0.5 mg) are sufficient to induce IL-4 pro-
duction by and death of peripheral NKT cells. Moreover, perhaps not surprising that TCR ligation leads rapidly
to death in this lineage.anti-CD3e-induced IL-4 production has been reported
to be highest in spleen but low in bone marrow and A second molecule, IL-12, has been reported to acti-
vate NKT cells in vivo. Indeed, IL-12 induces NKT cell-absent in thymus (IL-4 production in liver has not been
reported). Similarly, NKT cell deletion induced by anti- mediated rejection of liver EL-4 metastases (Hashimoto
et al., 1995; Takeda et al., 1996; Cui et al., 1997). More-CD3e MAb was high in spleen but marginal in bone
marrow and absent in thymus. Thus, a strong correlation over, NKT cells isolated from the liver of IL-12 (Hashi-
moto et al., 1995; Kawamura et al., 1998) or LPS (Taka-exists between the level of IL-4 production by and dele-
tion of NKT cells in different organs. Together, these hashi et al., 1996)-treated mice are cytotoxic against
common murine tumor targets in vitro, and in the latterdata further support the notion that activation and death
of NKT cells in anti-CD3e-treated mice are tightly linked case activation of NKT cells was shown to be mediated
by IL-12 produced by Kupffer cells. The ultimate fate ofprocesses.
Although both NKT cells and conventional T cells ex- NKT cells in IL-12-treated mice is controversial. Hashi-
moto et al. (1995) have reported that a population ofpress the TCR/CD3 complex, the doses of anti-CD3e
MAb required to delete conventional T cells in vivo are TCRabdim NK1.1bright cells appears in the liver of IL-12-
treated mice. In contrast, Emoto et al. (1997a, 1997b)dramatically higher. Whereas NKT cells in liver and
spleen are deleted by doses of less than 1 mg of anti- have shown that IL-12 (and Bacille Calmette GueÂ rin)
induces depletion of liver NKT cells. In agreement withCD3e MAb, 100-fold more MAb is necessary to delete
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the latter study, we show here that IL-12 induces dele- that the development of this population of bone marrow
NKT cells may depend on the thymus. To resolve thistion of liver NKT cells within 1 day after administration.
These apparently conflicting data may be reconciled by question, further experiments will be required to deter-
mine the long-term self-renewal capacity of bone mar-proposing that AICD of NKT cells occurs in IL-12-treated
mice but that differences in the quality and/or dose of row NKT cells in adult thymectomized mice.
In conclusion, our data reveal a unique and tightlyinjected IL-12 influence the extent and kinetics of NKT
cell death. regulated control of peripheral NKT cell homeostasis.
Upon activation by TCR cross-linking or certain cyto-In addition to its effects on NKT cells, IL-12 is known
to be a potent activator of proliferation and IFN-g pro- kines (such as IL-12), peripheral NKT cells in liver and
(to a lesser extent spleen) are rapidly deleted and re-duction by both NK cells and T cells (Trinchieri, 1995).
Nevertheless, as was the case for anti-CD3e MAb, IL- placed by NKT cells that have been generated via de
novo proliferation in bone marrow. The physiological12 induced a selective deletion of liver NKT cells without
any apparent effect on NK cells or T cells. These data rationale for this rapid turnover of activated NKT cells
remains unclear. One interesting possibility might beemphasize the fact that peripheral NKT cells are particu-
larly prone to AICD in vivo, irrespective of the means by that NKT cell effector functions (such as cytokine pro-
duction and cytotoxicity) are only required during thewhich they are activated.
Rapid regeneration of peripheral NKT cells was achieved early stages of a systemic immune response, prior to
activation of conventional T cells. According to this sce-via proliferation that occurred in bone marrow of both
anti-CD3e- and IL-12-treated mice. Bone marrow thus nario, the continued presence of activated NKT cells
might interfere with the appropriate evolution of an anti-appears to be a reservoir of NKT cells that can undergo
proliferation to repopulate the periphery. The existence gen-specific T cell response. Whatever the explanation,
the rapid turnover of NKT cells is reminiscent of otherof other sites of NKT cell proliferation (such as lymph
nodes and gut) is not formally excluded, although their cells of the innate immune system (such as macro-
phages and neutrophils) that are destined to die as sooncontribution to homeostasis should be minor since the
number of NKT cells is very low in these organs (Bende- as their effector function has been accomplished (Whyte
et al., 1993; Munn et al., 1995).lac et al., 1997). An important question however is why
the anti-CD3e MAb and IL-12 treatments induced dele-
tion of peripheral (liver and spleen) NKT cells while they Experimental Procedures
induced marginal deletion of bone marrow NKT cells
Chemicalsfollowed by extensive proliferation. Several hypotheses
5-Bromo-29-deoxyuridine (BrdU), propidium iodide (PI), and saponinmay explain these puzzling observations. First, bone
were purchased from Sigma (Buchs, Switzerland).
marrow may contain a majority of relatively immature
NKT cells that would be activated to proliferate upon Mice and Treatments
stimulation with anti-CD3e MAb or IL-12, whereas most Eight-week-old C57Bl/6 female mice were purchased from Harlan/
peripheral NKT cells in liver and spleen would be mature Netherlands (Horst, The Netherlands). Five-week-old C57Bl/6 fe-
male mice were thymectomized at Iffa Credo (L'Arbresle, France)and die. Second, the local microenvironment of these
and used at the age of 8 to 12 weeks. Anti-CD3e MAb (0.2 mg) andtissues, especially in terms of particular APCs (such as
IL-12 (Schoenhaut et al., 1992) (0.5 mg) were injected i.v. in 200 mlKupffer cells in liver or mature dendritic cells in spleen),
of PBS. For BrdU treatment, mice were either injected twice i.p.
may influence the outcome of anti-CD3e MAb and IL- with 2 mg of BrdU in 400 ml of PBS or fed for the indicated period
12 stimulation of NKT cells by cross-linking different of time with drinking water containing 1 mg/ml BrdU and 5%
amounts of anti-CD3e MAb and/or producing different D-glucose.
types of cytokines. Third, deletion of peripheral NKT
Cell Preparationcells in anti-CD3e MAb- or IL-12-treated mice may indi-
Single cell suspensions were prepared from the liver, spleen, thy-rectly trigger the regeneration of NKT cells in bone mar-
mus, and bone marrow. Total liver cells were resuspended in 40%row, for example by a hormonal feedback mechanism.
isotonic Percoll solution (Pharmacia, Uppsala, Sweden) and under-In contrast, the lack of effect of anti-CD3e MAb on thy-
laid with 80% isotonic Percoll solution. Centrifugation for 20 min at
mus NKT cells is certainly explained by the low penetra- 2000 rpm isolated the mononuclear cells (small resting and blasts)
tion of systemic proteins into the thymus (Raviola and at the 40%±80% interface. The cells were washed twice with PBS
containing 2% FCS. Spleen cells and bone marrow (femur, tibia)Karnovsky, 1972; Yoshimoto and Paul, 1994).
cells were resuspended in DMEM supplemented with 5% FCS andIt is important to emphasize that the key role of bone
1% Hepes (FH-med) and loaded onto 10 ml nylon wool columnsmarrow described here for short term NKT cell homeo-
that were preincubated overnight at 378C with FH-med. The columnsstasis in adult mice does not necessarily imply that NKT
were incubated for 45 min at 378C, and the nonadherent cells (de-
cell development is thymus-independent. Indeed, NKT pleted of B cells and monocytes) were harvested by washing the
cell development has been shown in several instances columns with 20 ml of FH-med. Thymocytes were resuspended in
to be severely impaired in extrathymic tissues (including PBS containing 2% FCS together with a 1:10 dilution of J11d (anti-
HSA) hybridoma culture supernatant. After an incubation of 45 minbone marrow) in bothcongenitally athymic (Sykes, 1990;
at 48C, the cells were washed and incubated for another 45 min atLevitsky et al., 1991) and neonatally thymectomized
378C with an appropriate dilution of Rabbit complement. The viablemice (Hammond et al., 1998a), suggesting that NKT cell
mature (HSA2) thymocytes were isolated and washed twice.
precursors (or regulatory influences required for their
development) reside in the thymus. It is possible there- Flow Cytometry
fore that a population of bone marrow NKT cells is able A maximum of 1 3 106 cells were preincubated with 100 ml of 2.4G2
to proliferate and maintain homeostasis of the peripheral culture supernatant to block Fcg receptors. Cells were then washed
and incubated with the indicated MAb conjugates for 40 min in aNKT cell pool, even in the absence of the thymus, but
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total volume of 100 ml of PBScontaining 2% FCS. Cells were washed Bendelac, A., Hunziker, R.D., and Lantz, O. (1996). Increased in-
terleukin 4 and immunoglobulin E production in transgenic miceand, if required, incubated with streptavidin conjugates for 20 min.
overexpressing NK1 T cells. J. Exp. Med. 184, 1285±1293.After a further wash, cells were resuspended in PBS containing 2%
FCS and analyzed on a FACScan flow cytometer (Becton-Dickinson, Bendelac, A., Rivera, M.N., Park, S.H., and Roark, J.H. (1997). Mouse
San Jose, CA). For Annexin V staining, cells were incubated for 15 CD1-specific NK1 T cells: development, specificity, and function.
min with the protein in a Ca21-containing medium, following the Annu. Rev. Immunol. 15, 535±562.
manufacturer's protocol (Nexins Research, Kattendijke, The Nether- Boehme, S.A., and Lenardo, M.J. (1993). Propriocidal apoptosis of
lands), and 0.5mg/ml propidium iodide was added to the cells before mature T lymphocytes occurs at S phase of the cell cycle. Eur. J.
analysis. For intracellular stainings, cells were first surface-labeled Immunol. 23, 1552±1560.
and fixed 15 min with 2% paraformaldehyde in PBS. Cells were
Chen, H., and Paul, W.E. (1997). Cultured NK1.11 CD41 T cells pro-washed and incubated for 1 hr with PE-conjugated MAb in PBS
duce large amounts of IL-4 and IFN-g upon activation by anti-CD3containing 2% FCS and 0.5% saponin. After an additional 30 min
or CD1. J. Immunol. 159, 2240±2249.incubation in saponin-containing buffer in the absence of MAb, cells
Chen, Y.H., Chiu, N.M., Mandal, M., Wang, N., andWang, C.R. (1997).were washed, resuspended in PBS containing 2% FCS, and ana-
Impaired NK11 T cell development and early IL-4 production in CD1-lyzed.
deficient mice. Immunity 6, 459±467.
Cui, J., Shin, T., Kawano, T., Sato, H., Kondo, E., Toura, I., Kaneko,Antibodies
Y., Koseki, H., Kanno, M., and Taniguchi, M. (1997). RequirementAnti-CD3e MAb (145.2C11) used for intravenous injection was
for Va14 NKT cells in IL-12-mediated rejection of tumors. Sciencepurified on a protein G column and resuspended in PBS. For flow
278, 1623±1626.cytometry, PE- or biotin-conjugated anti-NK1.1 MAb (PK136) was
Emoto, M., Emoto, Y., and Kaufmann, S.H. (1997a). Bacille Calmettepurchased from Pharmingen (San Diego, CA). Biotin- or FITC-conju-
Guerin and interleukin-12 down-modulate interleukin-4-producinggated anti-CD3 MAb (17A2) and anti-CD4 MAb (GK1.5) and PE-
CD41 NK11 T lymphocytes. Eur. J. Immunol. 27, 183±188.conjugated anti-Vb8.2 MAb (F23.2) were produced at the Ludwig
Institute. FITC-conjugated anti-BrdU MAb and Annexin V were pur- Emoto, M., Emoto, Y., and Kaufmann, S.H. (1997b). TCR-mediated
chased from Becton-Dickinson (San Jose, CA) and Nexins Research target cell lysis by CD41NK11 liver T lymphocytes. Int. Immunol. 9,
(Kattendijke, The Netherlands), respectively. 563±571.
Hammond, K., Cain, W., van Driel, I., and Godfrey, D (1998a). Three
day neonatal thymectomy selectively depletes NK1.11 T cells. Int.BrdU and PI Stainings
Immunol., in press.Mice were fed with BrdU, and the cells isolated from the different
organs were first preincubated with 2.4G2 culture supernatant, Hammond, K.J.L., Poulton, L.D., Palmisano, L.J., Silveira, P.A., God-
washed, and stained for NK1.1 and CD3. NK1.11 CD31 cells (NKT frey, D.I., and Baxter, A.G. (1998b). ab1 CD42CD82 (NKT) thymo-
cells) were then purified (z95% purity) by electronic sorting on a cytes prevent insulin dependent diabetes mellitus in NOD/Lt mice
FACStar plus (Becton-Dickinson, San Jose, CA) and a maximum of by the influence of IL-4 and/or IL-10. J. Exp. Med. 187, 1047±1056.
5 3 105 sorted cells were fixed in 200 ml of 70% ethanol overnight Hashimoto, W., Takeda, K., Anzai, R., Ogasawara, K., Sakihara, H.,
at 48C. Cells were then successively washed and incubated at room Sugiura, K., Seki, S., and Kumagai, K. (1995). Cytotoxic NK1.1 Ag1
temperature in HCl 3N for 20 min, Na2B4O7 0.1 M for 3 min, and 15 ab T cells with intermediate TCR induced in the liver of mice by IL-
ml of anti-BrdU MAb for 1 hr. Cells werewashed and finally incubated 12. J. Immunol. 154, 4333±4340.
in 200 ml of PBS containing 2% FCS and 12.5 mg/ml of PI, together
Hirsch, R., Eckhaus, M., Auchincloss, H., Jr., Sachs, D.H., and Blue-with 50 mg/ml of RNAse A in 100 ml STE buffer (100 mM Tris base,
stone, J.A. (1988). Effects of in vivo administration of anti-T3 mono-100 mM NaCl, and 5 mM EDTA at pH 7.5) for 5 min at 378C. Cells
clonal antibody on T cell function in mice. I. Immunosuppression ofwere resuspended in PBS containing 2% FCS and analyzed on a
transplantation responses. J. Immunol. 140, 3766±3772.
FACScan flow cytometer (Becton-Dickinson, San Jose, CA).
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